Ototoxicity beyond platinum-based derivatives
Cancer Chemotherapy and Pharmacology · 2026
DOI: 10.1007/s00280-026-04944-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2026. Verfasst von Cecília Vieira Peruch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Otoacoustic Emissions, Spontaneous, Ototoxicity, Antineoplastic Agents, Platinum Compounds. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal De Ciências Da Saúde De Porto Alegre.
Abstract (Originalsprache)
Purpose
Ototoxicity caused by chemotherapy is a growing problem. Literature highlights the effects of platinum compounds. However, other chemotherapy drugs also have demonstrated audiological changes. The objective of this study was to compare pre- and post-treatment distortion product otoacoustic emissions (DPOAEs) in adult patients undergoing different chemotherapy regimens.
Methods
Cohort study comprising 174 individuals receiving chemotherapy (CT) between April 2022 and December 2023. DPOAE were evaluated in all patients at 2 kHz, 4 kHz, 6 kHz, 8 kHz, 10 kHz, and 12 kHz, before initiating chemotherapy and after completing the treatment. For differential analysis, the protocols were grouped into CT with platinum-based agents and other protocols.
Results
A reduction in response in at least one frequency of the DPOAE test was observed in 79% of the patients. 81% of those who received CT without platinum derivatives exhibited alterations in post-treatment examinations, whereas in the group with platinum-based compounds, alterations were observed in 79% of the subjects. Different percentages of response deterioration were observed across frequencies: 27.6% at 2 kHz, 24.6% at 4 kHz, 41.2% at 6 kHz, 58.8% at 8 kHz, 57.4% at 10 kHz, and 72.4% at 12 kHz. The ototoxic effect of chemotherapy protocols, with and without platinum, was more pronounced at higher frequencies, with no statistically significant difference between the groups.
Conclusion
Chemotherapy has shown signs of ototoxicity through changes in DPOAEs in the sample studied. The ototoxic effects were similar between drug protocols with and without platinum, highlighting the need for audiological monitoring in all chemotherapy patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil.
- Santa Casa de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
- Department of Speech Therapy, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brasil.
- Graduate Program in Rehabilitation Sciences,, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil.
- Department of Speech Therapy, Federal University of Minas Gerais (UFMG), Minas Gerais, Brazil.
- Department of Pharmacosciences, Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), St. Sarmento Leite, 287, Porto Alegre, 90050-170, Rio Grande do Sul, Brazil. elianedal@ufcsp…
Förderung
- Universidade Federal De Ciências Da Saúde De Porto Alegre
Zitieren
APA
Peruch, C. V., Machado, M. S., Martins, V. B., de Oliveira Goulart, F., Batista Berbert, M. C., & Dallegrave, E. (2026). Ototoxicity beyond platinum-based derivatives. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-026-04944-3
Vancouver
Peruch CV, Machado MS, Martins VB, de Oliveira Goulart F, Batista Berbert MC, Dallegrave E. Ototoxicity beyond platinum-based derivatives. Cancer Chemotherapy and Pharmacology. 2026. doi:10.1007/s00280-026-04944-3
BibTeX
@article{Peruch2026,
author = {Peruch, Cecília Vieira and Machado, Marcia Salgado and Martins, Vera Beatris and de Oliveira Goulart, Felipe and Batista Berbert, Monalise Costa and Dallegrave, Eliane},
title = {Ototoxicity beyond platinum-based derivatives},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2026},
doi = {10.1007/s00280-026-04944-3}
}
EUVIMED